ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet 28 Day Pack

RxCUI: 2696887
RxNorm name: ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet 28 Day Pack
Display name: ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet 28 Day Pack
Full name: ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet 28 Day Pack
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
FEMLYV	NORETHINDRONE ACETATE/ETHINYL ESTRADIOL	Millicent US, Inc.	a3c99fc1-9b05-4f0a-ad00-5e3e206302c9	2025-09-03	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2696887

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
a3c99fc1-9b05-4f0a-ad00-5e3e206302c9	ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet 28 Day Pack	SY	3	These highlights do not include all the information needed to use FEMLYV™ safely and effectively. See full prescribing information for FEMLYV. FEMLYV (norethindrone acetate and ethinyl estradiol orally disintegrating tablets) Initial U.S. Approval: 1968	20250903
a3c99fc1-9b05-4f0a-ad00-5e3e206302c9	ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet 28 Day Pack	PSN	3	These highlights do not include all the information needed to use FEMLYV™ safely and effectively. See full prescribing information for FEMLYV. FEMLYV (norethindrone acetate and ethinyl estradiol orally disintegrating tablets) Initial U.S. Approval: 1968	20250903
a3c99fc1-9b05-4f0a-ad00-5e3e206302c9	{24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet) / 4 (inert ingredients 1 MG Disintegrating Oral Tablet) } Pack	GPCK	3	These highlights do not include all the information needed to use FEMLYV™ safely and effectively. See full prescribing information for FEMLYV. FEMLYV (norethindrone acetate and ethinyl estradiol orally disintegrating tablets) Initial U.S. Approval: 1968	20250903